Methylene Blue and Sleep: Does Taking It at Night Matter?

Nobody has shown whether taking methylene blue at night matters for sleep. We searched PubMed on October 1, 2026 and found no human trial that measured sleep in people taking it. The FDA label for ProvayBlue on DailyMed does not list insomnia or sleep problems among its adverse reactions, but that label covers a hospital IV product, so it cannot settle the question for supplements. Methylene blue is not a sleep aid, and we are not suggesting it is one.

• Label check: we searched the full text of the ProvayBlue label (published June 12, 2025) and two generic injection labels for insomnia and sleep and found zero matches (FDA label for ProvayBlue on DailyMed).
• Half-life: the label gives approximately 24 hours in humans (FDA label for ProvayBlue on DailyMed). Volunteer studies report anywhere from about 5 to 27 hours depending on route and formulation (Peter 2000, Repici 2012).
• Mechanism: methylene blue inhibits MAO-A in a test tube (Ramsay 2007), and a rat study found higher pineal melatonin content (Oxenkrug 2007). Neither one measured sleep.
• Human sleep data: none that we could find. The animal work is thin and does not measure what you would want to know.

Important: The FDA label for methylene blue injection (ProvayBlue) warns about serotonin syndrome with serotonergic medications, including SSRIs and MAOIs. Review the full adverse medications list before use. If your sleep gets worse, ask a clinician.

Most people who ask about sleep want one thing: is insomnia a known reaction? So we went to the source. The FDA label for ProvayBlue on DailyMed is the prescribing information for the injectable form used in hospitals for acquired methemoglobinemia. We pulled the full text and searched it for the words insomnia and sleep. Neither one appears. We ran the same search on two generic methylene blue injection labels (Hikma and Zydus) and got the same result.

Here is what the ProvayBlue label does list. In its clinical trial of 31 adults, the adverse reactions reported in at least 2 percent of patients were headache, hypokalemia, diarrhea, hypomagnesemia, myoclonus, nausea, and seizure-like phenomena, according to section 6.1 of the FDA label for ProvayBlue on DailyMed. Section 5.6 of that label says treatment may cause confusion, dizziness, and disturbances in vision, and tells patients to avoid driving or operating machinery until those effects go away.

The question behind "does night matter" is really about how long methylene blue hangs around. The FDA label for ProvayBlue on DailyMed says methylene blue has a half-life of approximately 24 hours in humans, and that about 40 percent is excreted in urine unchanged. A half-life is how long it takes the blood level to drop by half. By that number, a morning dose is still partly present at bedtime, and a bedtime dose is still partly present the next morning. That is simple math from the label, not a sleep finding.

Published volunteer studies do not agree on one number, which is worth knowing. Here is what we could verify:

Peter and colleagues also found that oral methylene blue had a much lower area under the curve than IV in the same volunteers (Eur J Clin Pharmacol, 2000). So route matters, and the formulation matters. None of these studies tested a supplement capsule or a drop, and none measured sleep.

If you want the full picture on clearance, our guide on how long methylene blue stays in your system walks through it. For the practical side of daily use, see how to take methylene blue.

You will see sleep claims built on one mechanism: methylene blue inhibits monoamine oxidase A, or MAO-A. That part is real. Ramsay and colleagues tested purified human enzymes and found methylene blue was a potent, reversible inhibitor of MAO-A (Br J Pharmacol, 2007). The FDA label says the same thing in plain terms, noting in section 7 that literature reports suggest ProvayBlue is a potent reversible inhibitor of monoamine oxidase (FDA label for ProvayBlue on DailyMed). That is exactly why the serotonin syndrome warning exists.

The jump from MAO-A to sleep is where the evidence runs out. The only bridge we found is rodent work on melatonin. Oxenkrug and colleagues reported that methylene blue and related dyes inhibited MAO-A and raised N-acetylserotonin and melatonin content in rat pineal glands (Ann N Y Acad Sci, 2007). The authors were studying a possible antidepressant mechanism, and they did not measure sleep. In a separate rat jet lag model, methylene blue attenuated light-induced disruption of the N-acetylserotonin rhythm but not the melatonin rhythm (CNS Spectr, 2003).

We also searched PubMed for methylene blue together with REM sleep or rapid eye movement in the title or abstract and got zero results. So we will not claim any REM effect, good or bad. If you want the jet lag angle specifically, that is covered in our jet lag and circadian rhythm post.

A PubMed search for methylene blue and sleep in the title or abstract returns 20 results as of October 1, 2026. We read the titles of all 20. Most are surgical dye, pain injection, or gastric balloon papers where the word sleep shows up in passing. Three are sleep-adjacent mouse studies, listed below, and one is the rat jet lag paper covered above. A search limited to randomized controlled trials with sleep, circadian, insomnia, REM, or wakefulness returned two trials, and both are about pain injections.

So, after reading all of it: there is no human sleep trial, no polysomnography study, and no sleep diary study of methylene blue that we could find. The mouse work shows methylene blue is used in sleep research as a tool. It does not show what it does to your night. The Talarek result is worth one practical takeaway: if you take any sedating medication, tell your clinician before adding methylene blue. Nutricel's drug interactions guide lays out the bigger list.

We do not know, and anyone who says they do is going past the data. Here is what we can say with sources behind it: the half-life means timing is not a clean switch (FDA label for ProvayBlue on DailyMed), the MAO-A inhibition is real in test-tube work (Ramsay 2007), and no study has linked either one to sleep in people.

Our own best-time post and our jet lag post lean toward earlier in the day as a cautious default. Read that as precaution, not as a trial result. It is a reasonable guess that avoids the unknown, and this article is the reason we call it a guess.

Timing relative to meals is a separate question, covered in methylene blue and fasting: timing your dose. We are not going to tell you when to take anything. That is a decision for you and a clinician who knows your medications.

If your sleep gets worse after you start any supplement, treat it as information, not something to push through. Talk to a clinician or pharmacist and bring a full list of everything you take, including over-the-counter products, since the FDA label for ProvayBlue on DailyMed lists agitation among the symptoms of serotonin syndrome and names SSRIs, SNRIs, MAOIs, bupropion, buspirone, and several other drug classes to avoid combining with it.

A few practical points, none of them medical advice:

• Write down when you started, what else changed that week, and how your sleep felt. A clinician can do more with that than with a guess.
• Do not add a sleep product to fix a problem you have not diagnosed. Ask first.
• If you take an antidepressant or another serotonergic drug, do not wait. Raise it now. Our drug interactions guide explains why.

Do not take methylene blue if you are currently using:

• SSRIs, SNRIs, or MAOIs (the FDA label warns of serotonin syndrome)
• Any other serotonergic medication, including bupropion, buspirone, and opioids
• Anything else on the adverse medications list, until your clinician has reviewed it

Review the full adverse medications list and consult your healthcare provider before starting methylene blue in any form. Pregnant or nursing readers should read our guidance on that first.

None of them is a sleep product, and we are not recommending one for sleep. Blue Boost, Blue Boost Liquid, Blue Shroom, Blue Immune, Blue Renew, and Blue Remove all use the same methylene blue, so everything above applies to every one of them. Whether any of them fits you, and when, is a question for your clinician. If you do get the green light, pick the format that suits your routine and bring the product page to your appointment.

If your clinician does clear methylene blue for you, this is how our products differ:

Blue Boost is our core formula: 12mg of methylene blue per capsule.

Blue Immune combines methylene blue with copper, NAC, grass-fed beef liver, and vitamins A, C, and E.

Blue Shroom pairs methylene blue with six organic mushroom extracts including lion's mane, reishi, cordyceps, chaga, shiitake, and turkey tail.

Blue Renew is built around GlyNAC (glycine and N-acetyl cysteine) alongside methylene blue.

Blue Remove combines zeolite, curcumin, and nattokinase with methylene blue.

Blue Liquid delivers USP-grade methylene blue in a dropper bottle for liquid format.

The FDA label for the prescription product does not list insomnia, the half-life is long enough that a dose is never a clean on/off, and the MAO-A mechanism is real but has not been connected to human sleep. There is no human sleep trial. That is the whole evidence base, and it is thin.

FDA Label

MAO-A and Melatonin

Half-Life and Pharmacokinetics

Sleep-Adjacent Animal Studies

Further Reading

Sam Carlson, Marketing Developer at Nutricel

Sam is a marketing developer at Nutricel who writes the Nutricel Insights series to help our customers understand methylene blue and make informed choices, translating the published research into plain language. Sam is not a medical professional, and these articles are intended as education rather than medical advice. Every figure in this piece is tied to the studies listed in the references, and you should always speak with your healthcare provider before starting any supplement.